Molecular biological characteristics of Mitis group streptococci
https://doi.org/10.31631/2073-3046-2026-25-1-99-110
Abstract
Relevance. Mitis Group Streptococci (SMG), which belong to one of the 5 groups of greening streptococci, are a component of the normal human nasopharyngeal flora and include 17 known species. Among SMG, Streptococcus pneumoniae is the most common cause of a number of invasive and non-invasive human diseases that lead to high mortality rates worldwide. It is interesting to note that a number of studies have shown not only differences, but also similarities in the genes encoding the pathogenicity factors of S. pneumoniae and other members of the SMG, particularly Streptococcus oralis. Aims. To analyze and summarize the results of molecular genetic studies of the SMG and identify the features of the genetic diversity of the pathogen strains. Conclusion. The comparative analysis of the genomes of closely related SMG species revealed key common genes encoding the main pathogenicity factors, which allows for the optimization of the selection of candidate strains for development.
About the Authors
I. M. GruberRussian Federation
Irina M. Gruber – Dr. Sci. (Med.), Professor, Chief Researcher of the Laboratory of Experimental Microbiology
+7 (495) 916-20-47
O. M. Afanasyeva
Russian Federation
Olga M. Afanasyeva – Cand. Sci. (Med.), researcher of the Laboratory of experimental microbiology
+7 (495) 916-20-47
D. S. Vorobyev
Russian Federation
Denis S. Vorobyev – Cand. Sci. (Med.), Head of the Laboratory of Experimental Microbiology; Associate Professor of the Department of Microbiology, Virology and Immunology
+7 (495) 916-20-47
O. V. Zhigunova
Russian Federation
OlgaV. Zhigunova – junior researcher at the Laboratory of Experimental Microbiology
+7 (495) 916-20-47
References
1. Meditsinskaya mikrobiologiya. virusologiya i immunologiya. Atlas-rukovodstvo: Uchebnoye posobiye. Pod. red. A.S. Bykova. V.V. Zvereva.Moskva: Meditsinskoye informatsionnoye agentstvo. 2018. – 416 s. – ISBN 978-5-9986-0307-5 (In Russ.)
2. Mayanskiy NA, Kvarchiya AZ, Brzhozovskaya EA, et al. Species diversity and sensitivity to antibiotics against oral streptococci isolated in children. Russian Pediatric Journal. 2019; 22(3):153–161. (In Russ). doi: 10.18821/1560-9561-2019-22-3-153-161
3. Gudiol C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19(5):474–479. doi: 10.1111/j.1469-0691.2012.03879.x
4. Marín M, Gudiol C, Garcia-Vidal C, et al. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore). 2014;93(3):143–149. doi: 10.1097/MD.0000000000000026
5. Kaytukov AO, Glushkova EV, Briko NI, et al. Soft Tissue Infections of Streptococcal Etiology in the Purulent-Surgical Department of a Multidisciplinary Hospital. Epidemiology and Vaccinal Prevention. 2025;24(2):14–23. (In Russ.) doi: 10.31631/2073-3046-2025-24-2-14-23
6. Patel S, Gupta RS. Robust demarcation of fourteen different species groups within the genus Streptococcus based on genome-based phylogenies and molecular signatures. Infect Genet Evol. 2018;66:130–151. doi: 10.1016/j.meegid.2018.09.020
7. Imai K, Nemoto R, Kodana M, et al. Rapid and accurate species adentification of Mitis Group Streptococci using the MinION Nanopore Sequencer. Front Cell Infect Microbiol. 2020;10(11). Available at: https://www.frontiersin.org/articles/10.3389/fcimb.2020.00011/full. Accessed: 30.01.2020. (In Russ).
8. Kilian M, Riley DR, Jensen A, et al. Parallel evolution of Streptococcus pneumoniae and Streptococcus mitis to pathogenic and mutualistic lifestyles. mBio. 2014;5(4):e01490–14. doi: 10.1128/mBio.01490-14
9. Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med. 2013;3(7):a010215. doi: 10.1101/cshperspect.a010215.
10. Johnston C, Hinds J, Smith A, et al. Detection of Large Numbers of Pneumococcal Virulence Genes in Streptococci of the Mitis Group. J Clin Microbiol. 2010;48(8):2762–2769. doi: 10.1128/JCM.01746-09
11. Madhour A, Maurer P, Hakenbeck R. Cell surface proteins in S. pneumoniae, S. mitis and S. oralis. Iran J Microbiol. 2011;3(2):58–67.
12. Kilian M, Tettelin H. Identification of Virulence-Associated Properties by Comparative Genome Analysis of Streptococcus pneumoniae, S. pseudopneumoniae, S. mitis, Three S. oralis Subspecies, and S. infantis. mBio. 2019;10(5):e01985–19. doi: 10.1128/mBio.01985-19
13. Skov Sørensen UB, Yao K, Yang Y, et al. Capsular Polysaccharide Expression in Commensal Streptococcus Species: Genetic and Antigenic Similarities to Streptococcus pneumoniae. mBio. 2016;7(6):e01844–16. doi: 10.1128/mBio.01844-16
14. Denapaite D, Brückner R, Hakenbeck R, Vollmer W. Biosynthesis of teichoic acids in Streptococcus pneumoniae and closely related species: lessons from genomes. Microb Drug Resist. 2012;18(3):344–358. doi: 10.1089/mdr.2012.0026
15. Beloshitskiy GV. Optokhin i ego ispolzovaniye dlya identifikatsii Streptococcus pneumoniae.Meditsinskiy alfavit. 2012;3(14):39–41. (In Russ.).
16. Sadowy E, Hryniewicz W. Identification of Streptococcus pneumoniae and other Mitis streptococci: importance of molecular methods. Eur J Clin Microbiol Infect Dis. 2020;39(12):2247–2256.
17. Lazareva. A.V. Mikrobiologicheskaya kharakteristika. mekhanizmy ustoychivosti k antibiotikam i molekulyarnaya epidemiologiya rezistentnykh form respiratornykh patogenov i gospitalnykh gramotritsatelnykh bakteriy[dissertation]. Moskva; 2019. Available at: https://www.sechenov.ru/upload/medialibrary/c57/tekst-dissertatsii.pdf. Accessed: 4 Sep 2025. (In Russ).
18. Rolo D, Simões AS, Domenech A, et al. Disease isolates of Streptococcus pseudopneumoniae and non-typeable S. pneumoniae presumptively identified as atypical S. pneumoniae in Spain. PLoS One. 2013;8(2):e57047. doi: 10.1371/journal.pone.0057047
19. Balsalobre L, Hernandez-Madrid A, Llull D, et al. Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible. J Clin Microbiol. 2006;44:4163–4171. doi: 10.1128/JCM.01137-06
20. Chang B, Morita M, Nariai A, et al. Invasive Streptococcus oralis Expressing Serotype 3 Pneumococcal Capsule, Japan. Emerg Infect Dis. 2022;28(8):1720–1722. doi: 10.3201/eid2808.212176
21. Blaschke AJ. Interpreting assays for the detection of Streptococcus pneumoniae. Clin Infect Dis. 2011;52(4):S331–S337. doi: 10.1093/cid/cir048
22. López R, García E. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev. 2004;28(5):553–80. doi: 10.1016/j.femsre.2004.05.002
23. Magomani V, Wolter N, Tempia S, et al. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol. 2014;52(9):3271–6. doi: 10.1128/JCM.01061-14
24. Llull D, López R, García E. Characteristic signatures of the lytA gene provide a basis for rapid and reliable diagnosis of Streptococcus pneumoniae infections. J Clin Microbiol. 2006;44(4):1250–6. doi: 10.1128/JCM.44.4.1250-1256.2006
25. Romero P, García E, Mitchell TJ. Development of a prophage typing system and analysis of prophage carriage in Streptococcus pneumoniae. Appl Environ Microbiol. 2009;75(6):1642–9. doi: 10.1128/AEM.02155-08
26. Morales M, García P, de la Campa AG, et al. Evidence of localized prophage-host recombination in the lytA gene, encoding the major pneumococcal autolysin. J Bacteriol. 2010;192(10):2624–32. doi: 10.1128/JB.01501-09
27. Ktari S, Ben Ayed NEH, Maalej S, et al. Clinical optochin resistant Streptococcus pneumoniae and Streptococcus pseudopneumoniae strains in Tunisia. J Infect Dev Ctries. 2021;15(5):672–677. doi: 10.3855/jidc.13106
28. Mironov KO, Platonov AE, Dunaeva EA, et al. Real-time PCR procedure for determination of Streptococcus pneumoniae serotypes. Journal of Microbiology, Epidemiology and Immunobiology. 2014;91(1):41–48. (In Russ.)
29. El Aila NA, Emler S, Kaijalainen T, et al. The development of a 16S rRNA gene based PCR for the identification of Streptococcus pneumoniae and comparison with four other species specific PCR assays. BMC Infect Dis. 2010;10(1):104. doi: 10.1186/1471-2334-10-104
30. Whatmore AM, Efstratiou A, Pickerill AP, et al. Genetic Relationships between Clinical Isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: Characterization of “Atypical” Pneumococci and Organisms Allied to S. mitis Harboring S. pneumoniae Virulence Factor-Encoding Genes. Infect Immun. 2000;68(3):1374–1382. doi: 10.1128/IAI.68.3.1374-1382.2000
31. Komyagina TM, Tryapochkina AS, Alyabieva NM, et al. Population structure and genetic characteristics of Streptococcus pneumoniae isolates from children with chronic respiratory diseases. Clinical Microbiology and Antimicrobial Chemotherapy. 2024;26(4):480–486. doi: 10.36488/cmac.2024.4.480-486. (In Russ.)
32. Pichichero M.E. Pneumococcal whole-cell and protein –based vaccines: Changing the paradigm. Expert Rev Vaccines. 2017;6(12):1181–1190. doi: 10.1080/14760584.2017.1393335
33. Isaksson J, Rasmussen M, Nilson B, et al. Comparison of species identification of endocarditis associated viridans streptococci using rnpB genotyping and 2 MALDI-TOF systems. Diagn Microbiol Infect Dis. 2015;81(4):240–245. doi: 10.1016/j.diagmicrobio.2014.12.007
34. Park HK, Lee HJ, Jeong EG, et al. The rgg gene is a specific marker for Streptococcus oralis. J Dent Res. 2010;89(11):1299–303. doi: 10.1177/0022034510378426
35. Kim W, Park HK, Hwang WJ, Shin HS. Simultaneous detection of Streptococcus pneumoniae, S. mitis, and S. oralis by a novel multiplex PCR assay targeting the gyrB gene. J Clin Microbiol. 2013;51(3):835–840. doi: 10.1128/JCM.02920-12
36. Teles C, Smith A, Ramage G, Lang S. Identification of clinically relevant viridans group streptococci by phenotypic and genotypic analysis. Eur J Clin Microbiol Infect Dis. 2011;30(2): 243–50. doi: 10.1007/s10096-010-1076-y
37. Velsko IM, Perez MS, Richards VP. Resolving phylogenetic relationships for Streptococcus mitis and Streptococcus oralis through coreand pan-genome analyses. Genome Biol Evol. 2019;11(4):1077–1087. doi: 10.1093/gbe/evz049
38. Galloway-Peña J, Sahasrabhojane P, Tarrand J, et al.GyrB Polymorphisms accurately assign invasive viridans group streptococcal species. J Clin Microbiol. 2014;52(8):2905–2912. doi: 10.1128/JCM.01068-14
39. Mironov KO, Gaponova II, Korchagin VI, et al. Antigenic and genetic characterization of Streptococcus pneumoniae strains isolated from patients with invasive and non-invasive pneumococcal infections by using high-throughput sequencing. Journal of microbiology, epidemiology and immunobiology. 2021;98(5):512–518. doi: 10.36233/0372-9311-144
40. Mironov КO, Gaponova II, Korchagin VI., et al. Detection of Streptococcus pneumoniae serotypes causing invasive and non-invasive infections using whole-genome sequencing. Clinical Microbiology and Antimicrobial Chemotherapy. 2024;26(4):396–400. doi: 10.36488/cmac.2024.4.396-400
41. Joyce LR, Youngblom MA, Cormaty H, et al. Comparative Genomics of Streptococcus oralis Identifies Large Scale Homologous Recombination and a Genetic Variant Associated with Infection. mSphere. 2022;7(6):e0050922. doi: 10.1128/msphere.00509-22
42. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257. doi: 10.1186/s13059-019-1891-0
43. Facklam R. What Happened to the Streptococci: Overview of Taxonomic and Nomenclature Changes Richard. Clinical Microbiology Reviews. 2002;15(4):613–630. doi: 10.1128/CMR.15.4.613–630.2002
44. Chi F, Nolte O, Bergmann C, et al. Crossing the barrier: evolution and spread of a major class of mosaic pbp2x in Streptococcus pneumoniae, S. mitis and S. oralis. Int J Med Microbiol. 2007;297(7-8):503–512. doi: 10.1016/j.ijmm.2007.02.009
45. Morais V, Texeira E, Suarez N. Next-Generation Whole-Cell Pneumococcal Vaccine. Vaccines. 2019;7(4):151. doi: 10.3390/vaccines7040151
46. Li S, Liang H, Zhao S-H, et al. Recent progress in pneumococcal protein vaccines. Front Immunol. 2023;14:1278346. doi: 10.3389/fimmu.2023.1278346
47. Hava D, Camilli А. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol. 2002;45(5):1389–1406.
48. Barocchi MA, Ries J, Zogaj X, et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A. 2006;103(8):2857–2862. doi: 10.1073/pnas.0511017103
49. Bagnoli F, Moschioni M, Donati C, et al. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol. 2008;190(15):5480–5492. doi: 10.1128/JB.00384-08
50. Zähner D, Gandhi AR, Yi H, Stephens DS. Mitis Group Streptococci Express Variable Pilus Islet 2 Pili. PLoS ONE. 2011;6(9):e25124.
51. King SJ, Whatmore AM, Dowson CG. NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis. J Bacteriol. 2005;187(15):5376-5386. doi: 10.1128/JB.187.15.5376–5386.2005
52. Jefferies J, Nieminen L, Kirkham LA, et al. Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis. J Bacteriol. 2007;189(2):627–632. doi: 10.1128/JB.01092-06
53. Zhou J, Sun T, Kang W, et al. Pathogenic and antimicrobial resistance genes in Streptococcus oralis strains revealed by comparative genome analysis. Genomics. 2020;112(5):3783–3793. doi: 10.1016/j.ygeno.2020.04.014
54. Expert Council «Vaccination against pneumococcal infection as a mean of reducing morbidity and mortality in the adult population from risk groups in the Russian Federation». Epidemiology and infectious diseases. Current items 2025; 15(2):101–104. (In Russ.). doi: 10.18565/epidem.2025.15.2.101-104
55. Afanasyeva OM, Gruber IM, Brzhozovskaja EA, Astashkina EA. Faktory patogennosti blizkorodstvennyh streptokokkov gruppy Mitis raznoj virulentnosti. Sbornik Trudov XI Mezhdunarodnoj nauchno-prakticheskoj konferencii «Molekuljarnaja diagnostika 2023». M., 2023. P. 305–306. (In Russ.).
56. Afanasyeva OM, Gruber IM, Vorobyev DS, et al. Comparative analysis of pathogenicity factors of closely related Mitis group streptococci and surface protein-containing antigens isolated from them. Epidemiology and Vaccinal Prevention. 2025;24(2):24–32. (In Russ.). doi: 10.31631/2073-3046-2025-24-2-24-32
Review
For citations:
Gruber I.M., Afanasyeva O.M., Vorobyev D.S., Zhigunova O.V. Molecular biological characteristics of Mitis group streptococci. Epidemiology and Vaccinal Prevention. 2026;25(1):99-110. (In Russ.) https://doi.org/10.31631/2073-3046-2026-25-1-99-110
JATS XML






























